ATE132192T1 - Rekombinantes produkt - Google Patents

Rekombinantes produkt

Info

Publication number
ATE132192T1
ATE132192T1 AT87302200T AT87302200T ATE132192T1 AT E132192 T1 ATE132192 T1 AT E132192T1 AT 87302200 T AT87302200 T AT 87302200T AT 87302200 T AT87302200 T AT 87302200T AT E132192 T1 ATE132192 T1 AT E132192T1
Authority
AT
Austria
Prior art keywords
minactivin
purification
biologically active
relates
recombinant product
Prior art date
Application number
AT87302200T
Other languages
English (en)
Inventor
Toni Marie Antails
Thomas Michael Barnes
Michelle Alison Clark
Peter Leonard Devine
Neil Howard Goss
Philip Ralph Lehrbach
Original Assignee
Biotech Australia Pty Ltd
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd, Univ Australian filed Critical Biotech Australia Pty Ltd
Application granted granted Critical
Publication of ATE132192T1 publication Critical patent/ATE132192T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8132—Plasminogen activator inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators
    • G01N2333/9723—Urokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
AT87302200T 1986-03-13 1987-03-13 Rekombinantes produkt ATE132192T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPH501786 1986-03-13
AUPH603386 1986-05-22
AUPH810086 1986-09-18
AUPH910486 1986-11-21

Publications (1)

Publication Number Publication Date
ATE132192T1 true ATE132192T1 (de) 1996-01-15

Family

ID=27424177

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87302200T ATE132192T1 (de) 1986-03-13 1987-03-13 Rekombinantes produkt

Country Status (13)

Country Link
US (1) US5426044A (de)
EP (1) EP0238275B1 (de)
JP (2) JP2589996B2 (de)
KR (1) KR960001820B1 (de)
CN (2) CN1032019C (de)
AT (1) ATE132192T1 (de)
CA (1) CA1338381C (de)
DE (1) DE3751646T2 (de)
DK (2) DK172400B1 (de)
IL (1) IL81879A (de)
NO (1) NO178504C (de)
NZ (1) NZ219608A (de)
WO (1) WO1987005628A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
CA2041638C (en) * 1989-09-05 2001-05-15 Peter L. Whitfeld Recombinant polynucleotide constructs suitable for providing secretion of pai-2
AU625018B2 (en) * 1989-12-20 1992-06-25 Biotech Australia Pty Limited Variants of pai-2
GB9026737D0 (en) * 1990-12-08 1991-01-30 Delta Biotechnology Ltd Cancer treatment
US5994309A (en) 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
CN102586187A (zh) * 2012-02-23 2012-07-18 深圳市中美康士生物科技有限公司 一种中性粒细胞体外保存方法及培养基
CN116375796A (zh) * 2022-11-24 2023-07-04 华南农业大学 一种来源于珍珠贝的抗炎肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
JPH0655152B2 (ja) * 1984-08-13 1994-07-27 バイオテクノロジー・オーストラリア・ピーテイーワイ・リミテツド ミナクチビンの製造方法
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation

Also Published As

Publication number Publication date
IL81879A (en) 1994-07-31
NO874704D0 (no) 1987-11-11
EP0238275A3 (en) 1989-05-10
NO178504C (no) 1996-04-10
EP0238275A2 (de) 1987-09-23
DK172400B1 (da) 1998-05-18
JPH08112094A (ja) 1996-05-07
DE3751646D1 (de) 1996-02-08
NZ219608A (en) 1991-05-28
KR880701073A (ko) 1988-07-25
WO1987005628A1 (en) 1987-09-24
DK595187A (da) 1988-07-21
CA1338381C (en) 1996-06-11
NO874704L (no) 1987-11-11
JP2660681B2 (ja) 1997-10-08
DE3751646T2 (de) 1996-10-17
DK27097A (da) 1997-03-13
JPS63503354A (ja) 1988-12-08
JP2589996B2 (ja) 1997-03-12
CN1032019C (zh) 1996-06-12
DK595187D0 (da) 1987-11-13
KR960001820B1 (ko) 1996-02-05
EP0238275B1 (de) 1995-12-27
NO178504B (no) 1996-01-02
CN87102725A (zh) 1987-11-11
US5426044A (en) 1995-06-20
CN1100957A (zh) 1995-04-05

Similar Documents

Publication Publication Date Title
ATE196650T1 (de) Stabile bakterizide proteine, welche die permeabilität erhöhen und pharmazeutische zusammensetzungen, diese enthaltend
ATE386800T1 (de) Immunogene chimäre umfassend nucleinsäuresequenzen, die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
NO882341L (no) Ekspresjon av humant proapolipoprotein a-i.
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
IT1153265B (it) Polipeptidi contenenti la sequenza degli amminoacidi dell'interferone umano immune (interferone umano gamma), relativi veicoli di espressione, loro procedimento di preparazione, composizioni farmaceutiche contenenti tali polipeptidi
DE3650540D1 (de) Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
ATE91722T1 (de) Pferde-gamma-interferon.
IL85020A0 (en) Pancreatic secretory trypsin inhibitor and variants thereof,process expression vector and recombinant host therefor and pharmaceutical compositions containing it
DE69117123D1 (de) Menschliches MK Gen und Protein-Sequenz
DE3751646D1 (de) Rekombinantes Produkt
DE69132889D1 (de) Überlegende thrombomodulinanaloga zur pharmazeutischen verwendung
DK0652903T3 (da) Nyt humant rekombinant gammainterferon
DE69737766D1 (de) Zusammensetzungen von stammzellfaktor (scf)-analogen und auf diese bezogene verfahren
NO930428L (no) Proteinstrukturen til plantetoksingelonin
EP0261403A3 (de) Polypeptide des Rhinovirusstammes HRV89 sowie die hierfür codierenden DNA-Moleküle
ATE79638T1 (de) Polypeptide, deren kodierende peptide und methode zur herstellung dieser peptide und dnas.
DE602004019556D1 (de) Neues plexin-polypeptid, dieses codierende dna und verwendung davon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties